nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—Etoposide—uterine cancer	0.235	0.542	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—uterine cancer	0.199	0.458	CbGbCtD
Salicylate-sodium—PTGS1—oviduct—uterine cancer	0.0104	0.147	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—AKR1C1—uterine cancer	0.00786	0.427	CrCbGaD
Salicylate-sodium—PTGS1—artery—uterine cancer	0.00686	0.0972	CbGeAlD
Salicylate-sodium—PTGS2—artery—uterine cancer	0.00655	0.0929	CbGeAlD
Salicylate-sodium—Salicylic acid—AKR1C1—uterine cancer	0.00647	0.351	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—uterine cancer	0.00409	0.222	CrCbGaD
Salicylate-sodium—PTGS2—myometrium—uterine cancer	0.00317	0.0449	CbGeAlD
Salicylate-sodium—PTGS1—epithelium—uterine cancer	0.0026	0.0369	CbGeAlD
Salicylate-sodium—PTGS1—uterine cervix—uterine cancer	0.00258	0.0365	CbGeAlD
Salicylate-sodium—PTGS1—smooth muscle tissue—uterine cancer	0.0025	0.0355	CbGeAlD
Salicylate-sodium—PTGS2—epithelium—uterine cancer	0.00248	0.0352	CbGeAlD
Salicylate-sodium—PTGS2—uterine cervix—uterine cancer	0.00246	0.0349	CbGeAlD
Salicylate-sodium—PTGS1—renal system—uterine cancer	0.00241	0.0342	CbGeAlD
Salicylate-sodium—PTGS2—smooth muscle tissue—uterine cancer	0.00239	0.0339	CbGeAlD
Salicylate-sodium—PTGS1—endometrium—uterine cancer	0.00233	0.0331	CbGeAlD
Salicylate-sodium—PTGS2—renal system—uterine cancer	0.0023	0.0327	CbGeAlD
Salicylate-sodium—PTGS1—mammalian vulva—uterine cancer	0.00225	0.032	CbGeAlD
Salicylate-sodium—PTGS2—endometrium—uterine cancer	0.00223	0.0316	CbGeAlD
Salicylate-sodium—PTGS1—uterus—uterine cancer	0.00215	0.0305	CbGeAlD
Salicylate-sodium—PTGS2—uterus—uterine cancer	0.00205	0.0291	CbGeAlD
Salicylate-sodium—PTGS1—female reproductive system—uterine cancer	0.00193	0.0274	CbGeAlD
Salicylate-sodium—PTGS2—female reproductive system—uterine cancer	0.00185	0.0262	CbGeAlD
Salicylate-sodium—PTGS1—female gonad—uterine cancer	0.00176	0.0249	CbGeAlD
Salicylate-sodium—PTGS1—vagina—uterine cancer	0.00175	0.0248	CbGeAlD
Salicylate-sodium—PTGS2—female gonad—uterine cancer	0.00168	0.0238	CbGeAlD
Salicylate-sodium—PTGS2—vagina—uterine cancer	0.00167	0.0237	CbGeAlD
Salicylate-sodium—PTGS1—lymph node—uterine cancer	0.00113	0.016	CbGeAlD
Salicylate-sodium—PTGS2—lymph node—uterine cancer	0.00108	0.0153	CbGeAlD
Salicylate-sodium—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000944	0.00198	CcSEcCtD
Salicylate-sodium—Oliguria—Epirubicin—uterine cancer	0.00094	0.00197	CcSEcCtD
Salicylate-sodium—Decreased appetite—Progesterone—uterine cancer	0.000937	0.00196	CcSEcCtD
Salicylate-sodium—Erythema—Dactinomycin—uterine cancer	0.000933	0.00195	CcSEcCtD
Salicylate-sodium—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000931	0.00195	CcSEcCtD
Salicylate-sodium—Fatigue—Progesterone—uterine cancer	0.000929	0.00195	CcSEcCtD
Salicylate-sodium—Constipation—Progesterone—uterine cancer	0.000921	0.00193	CcSEcCtD
Salicylate-sodium—Pain—Progesterone—uterine cancer	0.000921	0.00193	CcSEcCtD
Salicylate-sodium—Extravasation—Doxorubicin—uterine cancer	0.000918	0.00192	CcSEcCtD
Salicylate-sodium—Ulcer—Epirubicin—uterine cancer	0.000915	0.00192	CcSEcCtD
Salicylate-sodium—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000912	0.00191	CcSEcCtD
Salicylate-sodium—Creatinine increased—Epirubicin—uterine cancer	0.00091	0.00191	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Progesterone—uterine cancer	0.000888	0.00186	CcSEcCtD
Salicylate-sodium—Cellulitis—Doxorubicin—uterine cancer	0.000881	0.00185	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Progesterone—uterine cancer	0.000881	0.00185	CcSEcCtD
Salicylate-sodium—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00184	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Doxorubicin—uterine cancer	0.000875	0.00183	CcSEcCtD
Salicylate-sodium—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00087	0.00182	CcSEcCtD
Salicylate-sodium—Oliguria—Doxorubicin—uterine cancer	0.000869	0.00182	CcSEcCtD
Salicylate-sodium—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00182	CcSEcCtD
Salicylate-sodium—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000859	0.0018	CcSEcCtD
Salicylate-sodium—Urticaria—Progesterone—uterine cancer	0.000856	0.00179	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Etoposide—uterine cancer	0.000852	0.00178	CcSEcCtD
Salicylate-sodium—Abdominal pain—Progesterone—uterine cancer	0.000852	0.00178	CcSEcCtD
Salicylate-sodium—Body temperature increased—Progesterone—uterine cancer	0.000852	0.00178	CcSEcCtD
Salicylate-sodium—Renal failure—Etoposide—uterine cancer	0.000849	0.00178	CcSEcCtD
Salicylate-sodium—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00178	CcSEcCtD
Salicylate-sodium—Ulcer—Doxorubicin—uterine cancer	0.000847	0.00177	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Etoposide—uterine cancer	0.000847	0.00177	CcSEcCtD
Salicylate-sodium—Creatinine increased—Doxorubicin—uterine cancer	0.000842	0.00176	CcSEcCtD
Salicylate-sodium—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.00176	CcSEcCtD
Salicylate-sodium—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000835	0.00175	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Epirubicin—uterine cancer	0.000827	0.00173	CcSEcCtD
Salicylate-sodium—Fluid retention—Epirubicin—uterine cancer	0.000822	0.00172	CcSEcCtD
Salicylate-sodium—Blood urea increased—Epirubicin—uterine cancer	0.000817	0.00171	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000804	0.00169	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000798	0.00167	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Progesterone—uterine cancer	0.000794	0.00166	CcSEcCtD
Salicylate-sodium—Oesophagitis—Epirubicin—uterine cancer	0.000791	0.00166	CcSEcCtD
Salicylate-sodium—Ecchymosis—Epirubicin—uterine cancer	0.000783	0.00164	CcSEcCtD
Salicylate-sodium—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000776	0.00162	CcSEcCtD
Salicylate-sodium—Asthenia—Progesterone—uterine cancer	0.000773	0.00162	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Etoposide—uterine cancer	0.000772	0.00162	CcSEcCtD
Salicylate-sodium—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.00162	CcSEcCtD
Salicylate-sodium—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.00162	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Doxorubicin—uterine cancer	0.000765	0.0016	CcSEcCtD
Salicylate-sodium—Pruritus—Progesterone—uterine cancer	0.000762	0.0016	CcSEcCtD
Salicylate-sodium—Oedema—Dactinomycin—uterine cancer	0.000761	0.0016	CcSEcCtD
Salicylate-sodium—Fluid retention—Doxorubicin—uterine cancer	0.000761	0.00159	CcSEcCtD
Salicylate-sodium—Infection—Dactinomycin—uterine cancer	0.000757	0.00158	CcSEcCtD
Salicylate-sodium—Blood urea increased—Doxorubicin—uterine cancer	0.000756	0.00158	CcSEcCtD
Salicylate-sodium—Sepsis—Epirubicin—uterine cancer	0.000751	0.00157	CcSEcCtD
Salicylate-sodium—Diarrhoea—Progesterone—uterine cancer	0.000737	0.00154	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Etoposide—uterine cancer	0.000733	0.00154	CcSEcCtD
Salicylate-sodium—Oesophagitis—Doxorubicin—uterine cancer	0.000732	0.00153	CcSEcCtD
Salicylate-sodium—Phlebitis—Epirubicin—uterine cancer	0.00073	0.00153	CcSEcCtD
Salicylate-sodium—Anorexia—Dactinomycin—uterine cancer	0.000726	0.00152	CcSEcCtD
Salicylate-sodium—Ecchymosis—Doxorubicin—uterine cancer	0.000724	0.00152	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000719	0.00151	CcSEcCtD
Salicylate-sodium—Dizziness—Progesterone—uterine cancer	0.000712	0.00149	CcSEcCtD
Salicylate-sodium—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0007	0.00147	CcSEcCtD
Salicylate-sodium—Sepsis—Doxorubicin—uterine cancer	0.000695	0.00146	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Epirubicin—uterine cancer	0.000693	0.00145	CcSEcCtD
Salicylate-sodium—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000691	0.00145	CcSEcCtD
Salicylate-sodium—Vomiting—Progesterone—uterine cancer	0.000685	0.00144	CcSEcCtD
Salicylate-sodium—Renal failure acute—Epirubicin—uterine cancer	0.000681	0.00143	CcSEcCtD
Salicylate-sodium—Rash—Progesterone—uterine cancer	0.000679	0.00142	CcSEcCtD
Salicylate-sodium—Dermatitis—Progesterone—uterine cancer	0.000679	0.00142	CcSEcCtD
Salicylate-sodium—Phlebitis—Doxorubicin—uterine cancer	0.000675	0.00141	CcSEcCtD
Salicylate-sodium—Headache—Progesterone—uterine cancer	0.000675	0.00141	CcSEcCtD
Salicylate-sodium—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.0014	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dactinomycin—uterine cancer	0.000662	0.00139	CcSEcCtD
Salicylate-sodium—Dysgeusia—Etoposide—uterine cancer	0.000661	0.00139	CcSEcCtD
Salicylate-sodium—Renal impairment—Epirubicin—uterine cancer	0.00066	0.00138	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—uterine cancer	0.000657	0.00138	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—uterine cancer	0.000651	0.00136	CcSEcCtD
Salicylate-sodium—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000646	0.00135	CcSEcCtD
Salicylate-sodium—Lethargy—Epirubicin—uterine cancer	0.000641	0.00134	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Epirubicin—uterine cancer	0.000641	0.00134	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000641	0.00134	CcSEcCtD
Salicylate-sodium—Nausea—Progesterone—uterine cancer	0.00064	0.00134	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—uterine cancer	0.00063	0.00132	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—uterine cancer	0.000628	0.00131	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000623	0.0013	CcSEcCtD
Salicylate-sodium—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000621	0.0013	CcSEcCtD
Salicylate-sodium—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000616	0.00129	CcSEcCtD
Salicylate-sodium—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000615	0.00129	CcSEcCtD
Salicylate-sodium—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000612	0.00128	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—uterine cancer	0.000611	0.00128	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—uterine cancer	0.000602	0.00126	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—uterine cancer	0.000602	0.00126	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Etoposide—uterine cancer	0.000594	0.00124	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—uterine cancer	0.000594	0.00124	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000594	0.00124	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Epirubicin—uterine cancer	0.000589	0.00123	CcSEcCtD
Salicylate-sodium—Convulsion—Etoposide—uterine cancer	0.000585	0.00123	CcSEcCtD
Salicylate-sodium—Dehydration—Epirubicin—uterine cancer	0.000585	0.00122	CcSEcCtD
Salicylate-sodium—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00058	0.00121	CcSEcCtD
Salicylate-sodium—Chest pain—Etoposide—uterine cancer	0.000575	0.0012	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Epirubicin—uterine cancer	0.000574	0.0012	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Epirubicin—uterine cancer	0.000572	0.0012	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—uterine cancer	0.000561	0.00118	CcSEcCtD
Salicylate-sodium—Confusional state—Etoposide—uterine cancer	0.000556	0.00116	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Etoposide—uterine cancer	0.000551	0.00115	CcSEcCtD
Salicylate-sodium—Infection—Etoposide—uterine cancer	0.000548	0.00115	CcSEcCtD
Salicylate-sodium—Abdominal distension—Epirubicin—uterine cancer	0.000547	0.00115	CcSEcCtD
Salicylate-sodium—Asthenia—Dactinomycin—uterine cancer	0.000546	0.00114	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—uterine cancer	0.000545	0.00114	CcSEcCtD
Salicylate-sodium—Dysphagia—Epirubicin—uterine cancer	0.000543	0.00114	CcSEcCtD
Salicylate-sodium—Asthma—Epirubicin—uterine cancer	0.000543	0.00114	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—uterine cancer	0.000541	0.00113	CcSEcCtD
Salicylate-sodium—Tachycardia—Etoposide—uterine cancer	0.000538	0.00113	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Etoposide—uterine cancer	0.000533	0.00112	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—uterine cancer	0.000531	0.00111	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—uterine cancer	0.000529	0.00111	CcSEcCtD
Salicylate-sodium—Anorexia—Etoposide—uterine cancer	0.000525	0.0011	CcSEcCtD
Salicylate-sodium—Bronchitis—Epirubicin—uterine cancer	0.000522	0.00109	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—uterine cancer	0.000521	0.00109	CcSEcCtD
Salicylate-sodium—Hypotension—Etoposide—uterine cancer	0.000515	0.00108	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—uterine cancer	0.000506	0.00106	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—uterine cancer	0.000503	0.00105	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—uterine cancer	0.000503	0.00105	CcSEcCtD
Salicylate-sodium—Paraesthesia—Etoposide—uterine cancer	0.000495	0.00104	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—uterine cancer	0.000494	0.00104	CcSEcCtD
Salicylate-sodium—Dyspnoea—Etoposide—uterine cancer	0.000491	0.00103	CcSEcCtD
Salicylate-sodium—Somnolence—Etoposide—uterine cancer	0.00049	0.00103	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—uterine cancer	0.000484	0.00101	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—uterine cancer	0.000484	0.00101	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—uterine cancer	0.000483	0.00101	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—uterine cancer	0.00048	0.00101	CcSEcCtD
Salicylate-sodium—Decreased appetite—Etoposide—uterine cancer	0.000479	0.001	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—uterine cancer	0.000476	0.000998	CcSEcCtD
Salicylate-sodium—Fatigue—Etoposide—uterine cancer	0.000475	0.000995	CcSEcCtD
Salicylate-sodium—Pain—Etoposide—uterine cancer	0.000471	0.000987	CcSEcCtD
Salicylate-sodium—Constipation—Etoposide—uterine cancer	0.000471	0.000987	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—uterine cancer	0.000457	0.000958	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—uterine cancer	0.000457	0.000957	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Etoposide—uterine cancer	0.000454	0.000951	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—uterine cancer	0.000452	0.000948	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Etoposide—uterine cancer	0.000451	0.000944	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—uterine cancer	0.000448	0.000939	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—uterine cancer	0.000441	0.000923	CcSEcCtD
Salicylate-sodium—Urticaria—Etoposide—uterine cancer	0.000438	0.000917	CcSEcCtD
Salicylate-sodium—Abdominal pain—Etoposide—uterine cancer	0.000436	0.000913	CcSEcCtD
Salicylate-sodium—Body temperature increased—Etoposide—uterine cancer	0.000436	0.000913	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—uterine cancer	0.000435	0.000911	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—uterine cancer	0.000433	0.000906	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—uterine cancer	0.000423	0.000886	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—uterine cancer	0.000411	0.000861	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—uterine cancer	0.000406	0.000851	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—uterine cancer	0.000405	0.000849	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—uterine cancer	0.000402	0.000843	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—uterine cancer	0.0004	0.000839	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—uterine cancer	0.000395	0.000828	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—uterine cancer	0.00039	0.000817	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—uterine cancer	0.000388	0.000814	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—uterine cancer	0.00038	0.000797	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—uterine cancer	0.000379	0.000793	CcSEcCtD
Salicylate-sodium—Diarrhoea—Etoposide—uterine cancer	0.000377	0.00079	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—uterine cancer	0.000375	0.000786	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—uterine cancer	0.000373	0.000781	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—uterine cancer	0.000371	0.000777	CcSEcCtD
Salicylate-sodium—Dizziness—Etoposide—uterine cancer	0.000364	0.000764	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—uterine cancer	0.000359	0.000753	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—uterine cancer	0.000357	0.000747	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—uterine cancer	0.00035	0.000734	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—uterine cancer	0.00035	0.000734	CcSEcCtD
Salicylate-sodium—Rash—Etoposide—uterine cancer	0.000347	0.000728	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—uterine cancer	0.000347	0.000727	CcSEcCtD
Salicylate-sodium—Headache—Etoposide—uterine cancer	0.000345	0.000723	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—uterine cancer	0.000345	0.000723	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—uterine cancer	0.000343	0.000719	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—uterine cancer	0.000339	0.000711	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—uterine cancer	0.000335	0.000701	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—uterine cancer	0.000333	0.000697	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—uterine cancer	0.00033	0.000692	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—uterine cancer	0.000328	0.000687	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—uterine cancer	0.000327	0.000686	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—uterine cancer	0.000322	0.000675	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—uterine cancer	0.000321	0.000673	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—uterine cancer	0.000314	0.000658	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—uterine cancer	0.000312	0.000653	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—uterine cancer	0.00031	0.000648	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—uterine cancer	0.000309	0.000647	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—uterine cancer	0.000309	0.000647	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—uterine cancer	0.000308	0.000645	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—uterine cancer	0.000307	0.000643	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—uterine cancer	0.000304	0.000637	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—uterine cancer	0.000303	0.000636	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—uterine cancer	0.000302	0.000632	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—uterine cancer	0.000299	0.000626	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—uterine cancer	0.000298	0.000625	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—uterine cancer	0.000297	0.000623	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—uterine cancer	0.000294	0.000617	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—uterine cancer	0.000289	0.000605	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—uterine cancer	0.000288	0.000604	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—uterine cancer	0.000286	0.000599	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—uterine cancer	0.000286	0.000599	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—uterine cancer	0.000284	0.000595	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—uterine cancer	0.000281	0.000589	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—uterine cancer	0.000279	0.000584	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—uterine cancer	0.000277	0.000581	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—uterine cancer	0.000276	0.000579	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—uterine cancer	0.000275	0.000577	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—uterine cancer	0.000275	0.000575	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—uterine cancer	0.000272	0.000571	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—uterine cancer	0.000272	0.00057	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—uterine cancer	0.000269	0.000563	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—uterine cancer	0.000267	0.00056	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—uterine cancer	0.000266	0.000558	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—uterine cancer	0.000264	0.000553	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—uterine cancer	0.000264	0.000553	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—uterine cancer	0.000257	0.000538	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—uterine cancer	0.000255	0.000534	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—uterine cancer	0.000255	0.000533	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—uterine cancer	0.000254	0.000532	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—uterine cancer	0.000253	0.000529	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—uterine cancer	0.000252	0.000527	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—uterine cancer	0.000248	0.000521	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—uterine cancer	0.000246	0.000516	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—uterine cancer	0.000245	0.000514	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—uterine cancer	0.000244	0.000512	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—uterine cancer	0.000244	0.000512	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—uterine cancer	0.000244	0.000512	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—uterine cancer	0.000244	0.000512	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—uterine cancer	0.000236	0.000494	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000234	0.00049	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—uterine cancer	0.000228	0.000477	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—uterine cancer	0.000227	0.000476	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—uterine cancer	0.000226	0.000473	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—uterine cancer	0.000226	0.000473	CcSEcCtD
Salicylate-sodium—Asthenia—Epirubicin—uterine cancer	0.000222	0.000464	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—uterine cancer	0.000219	0.000458	CcSEcCtD
Salicylate-sodium—Diarrhoea—Epirubicin—uterine cancer	0.000211	0.000443	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—uterine cancer	0.000211	0.000441	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—uterine cancer	0.000205	0.00043	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—uterine cancer	0.000204	0.000428	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—uterine cancer	0.000202	0.000424	CcSEcCtD
Salicylate-sodium—Vomiting—Epirubicin—uterine cancer	0.000196	0.000412	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—uterine cancer	0.000196	0.00041	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—uterine cancer	0.000195	0.000408	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—uterine cancer	0.000195	0.000408	CcSEcCtD
Salicylate-sodium—Headache—Epirubicin—uterine cancer	0.000194	0.000405	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—uterine cancer	0.000189	0.000396	CcSEcCtD
Salicylate-sodium—Nausea—Epirubicin—uterine cancer	0.000184	0.000384	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—uterine cancer	0.000182	0.000381	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—uterine cancer	0.00018	0.000378	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—uterine cancer	0.00018	0.000377	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—uterine cancer	0.000179	0.000375	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—uterine cancer	0.00017	0.000356	CcSEcCtD
